N Engl J Med 389(24):22212232 [DOI] [PubMed] [Google Scholar] 82.Tufail E, Sanyal S, Mithal A, Sanyal S, Chattopadhyay N (2025) The role of glucagon-like peptides in osteosarcopenia
The results revealed that the drastic inhibition of GLP-1 secretion, caused by the shutdown of the main pathway via the SSTRs-Gi axis, is the main cause of pasireotide-induced hyperglycemia
However, there was no significant improvement in fibrosis stage by semaglutide therapy
Key highlights Microdosing is defined as using very small, off-label doses that are far below standard therapeutic doses to get mild benefits with fewer side effects
Human evidence - Phase 3 TRIUMPH-4 (Eli Lilly, December 11, 2025) Adults with obesity and knee osteoarthritis
If you don't you should check it out